ANIP ANI PHARMACEUTICALS INC
Price Chart
Executive Summary
Seven corporate insiders at ANI Pharmaceuticals sold shares in the past week, including five open-market sales totaling $1.23 million and four non-cash tax withholding transactions totaling $2.14 million. The selling involved key executives, including the CEO, CFO, and multiple SVPs, with open-market dispositions representing approximately 0.08% of the company's $1.6B market cap.
Key Financial Metrics
Actionable Insight
Traders should monitor for potential downward pressure on ANIP shares, especially given the breadth of selling across the executive team. The absence of any offsetting insider buying and the concentration of sales among C-suite leaders may signal reduced confidence ahead of earnings or regulatory developments.
Key Facts
- Five open-market sales by senior executives totaling $1,228,501.87 in the past 7 days
- CEO Lalwani Nikhil did not sell shares directly but had 17,060 shares withheld for taxes ($1.26M value)
- CFO Carey and other SVPs also had shares withheld for taxes, adding $872,043.12 in non-cash dispositions
- Total insider share dispositions (cash + non-cash) in cluster: $3.37 million
- Open-market selling was distributed across multiple executives in established brands, rare disease, HR, and legal
- No insider purchases were reported in the cluster
Financial Impact
$1.23 million in open-market sales and $2.14 million in tax-related share surrenders over 7 days
Risk Factors
- Perception of insider pessimism due to coordinated timing of sales
- Potential for further selling if executives are exiting positions systematically
- Market reaction could amplify on light volume given the relatively small float typical in specialty pharma
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (9 trades, 7d window) | cluster-ANIP-1773437352172 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
4d ago
|
Insider Cluster
| $81.77 awaiting T+5 | awaiting T+5 | — | $81.68 (−0.11%) |
|
May 21, 2026
24d ago
|
8-K
| $82.72 $76.71 | ▼ −7.27% | ▼ −8.92% | $81.68 (−1.26%) |
|
May 13, 2026
4w ago
|
8-K
| $80.88 $80.32 | ▼ −0.69% | ▲ +0.47% | $81.68 (+0.99%) |
|
May 11, 2026
5w ago
|
Insider Cluster
| $78.71 $79.34 | ▲ +0.80% | ▲ +0.89% | $81.68 (+3.77%) |
|
May 8, 2026
5w ago
|
8-K
| $81.86 $79.58 | ▼ −2.79% | ▼ −4.25% | $81.68 (−0.22%) |
|
May 8, 2026
5w ago
|
Press Release
| $81.86 $79.58 | ▼ −2.79% | ▼ −4.25% | $81.68 (−0.22%) |
|
Apr 24, 2026
7w ago
|
Press Release
| $78.64 $79.45 | ▲ +1.03% | ▲ +0.12% | $81.68 (+3.87%) |
|
Apr 8, 2026
9w ago
|
Press Release
| $79.01 $76.48 | ▼ −3.20% | ▼ −6.72% | $81.68 (+3.38%) |
|
Apr 7, 2026
9w ago
|
8-K
| $79.01 $76.48 | ▼ −3.20% | ▼ −6.72% | $81.68 (+3.38%) |
|
Apr 7, 2026
9w ago
|
Press Release
| $79.47 $78.29 | ▼ −1.48% | ▼ −6.81% | $81.68 (+2.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access